PAX5 alterations in an infant case of KMT2A-rearranged leukemia with lineage switch

被引:3
|
作者
Nakajima, Koji [1 ]
Kubota, Hirohito [1 ]
Kato, Itaru [1 ]
Isobe, Kiyotaka [1 ]
Ueno, Hiroo [1 ]
Kozuki, Kagehiro [1 ]
Tanaka, Kuniaki [1 ]
Kawabata, Naoko [1 ]
Mikami, Takashi [1 ]
Tamefusa, Kosuke [2 ]
Nishiuchi, Ritsuo [2 ]
Saida, Satoshi [1 ]
Umeda, Katsutsugu [1 ]
Hiramatsu, Hidefumi [1 ]
Adachi, Souichi [3 ]
Takita, Junko [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto, Japan
[2] Kochi Hlth Sci Ctr, Dept Pediat, Kochi, Japan
[3] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan
关键词
infant leukemia; KMT2A rearrangement; lineage switch; PAX5; whole exome sequencing; CELL;
D O I
10.1111/cas.15380
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lineage switch is a rare event at leukemic relapse. While mostly known to occur in KMT2A-rearranged infant leukemia, the underlying mechanism is yet to be depicted. This case report describes a female infant who achieved remission of KMT2A-MLLT3-rearranged acute monocytic leukemia, but 6 months thereafter, relapsed as KMT2A-MLLT3-rearranged acute lymphocytic leukemia. Whole exome sequencing of the bone marrow obtained pre-post lineage switch revealed two somatic mutations of PAX5 in the relapse sample. These two PAX5 alterations were suggested to be loss of function, thus to have played the driver role in the lineage switch from acute monocytic leukemia to acute lymphocytic leukemia.
引用
收藏
页码:2472 / 2476
页数:5
相关论文
共 50 条
  • [41] Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia
    van Weelderen, Romy E.
    Harrison, Christine J.
    Klein, Kim
    Jiang, Yilin
    Abrahamsson, Jonas
    Alonzo, Todd
    Aplenc, Richard
    Arad-Cohen, Nira
    Bart-Delabesse, Emmanuelle
    Buldini, Barbara
    De Moerloose, Barbara
    Dworzak, Michael N.
    Elitzur, Sarah
    Navarro, Jose M. Fernandez
    Gamis, Alan
    Gerbing, Robert B.
    Goemans, Bianca F.
    Groot-Kruseman, Hester A. de
    Guest, Erin
    Ha, Shau-Yin
    Hasle, Henrik
    Kelaidi, Charikleia
    Lapillonne, Helene
    Leverger, Guy
    Locatelli, Franco
    Miyamura, Takako
    Noren-Nystrom, Ulrika
    Polychronopoulou, Sophia
    Rasche, Mareike
    Rubnitz, Jeffrey E.
    Stary, Jan
    Tierens, Anne
    Tomizawa, Daisuke
    Zwaan, C. Michel
    Kaspers, Gertjan J. L.
    BLOOD ADVANCES, 2024, 8 (12) : 3200 - 3213
  • [42] Single-cell transcriptomics reveals a distinct developmental state of KMT2A-rearranged infant B-cell acute lymphoblastic leukemia
    Eleonora Khabirova
    Laura Jardine
    Tim H. H. Coorens
    Simone Webb
    Taryn D. Treger
    Justin Engelbert
    Tarryn Porter
    Elena Prigmore
    Grace Collord
    Alice Piapi
    Sarah A. Teichmann
    Sarah Inglott
    Owen Williams
    Olaf Heidenreich
    Matthew D. Young
    Karin Straathof
    Simon Bomken
    Jack Bartram
    Muzlifah Haniffa
    Sam Behjati
    Nature Medicine, 2022, 28 : 743 - 751
  • [43] Selective inhibition of HDAC class IIA as therapeutic intervention for KMT2A-rearranged acute lymphoblastic leukemia
    Verbeek, Tamara C. A. I.
    Vrenken, Kirsten S.
    Arentsen-Peters, Susan T. C. J. M.
    Castro, Patricia Garrido
    van de Ven, Marieke
    van Tellingen, Olaf
    Pieters, Rob
    Stam, Ronald W.
    COMMUNICATIONS BIOLOGY, 2024, 7 (01)
  • [44] DYRK1A Is Required to Alleviate Replication Stress in KMT2A-Rearranged Acute Lymphoblastic Leukemia
    Hurtz, Christian
    Carroll, Martin P.
    Tasian, Sarah K.
    Wertheim, Gerald
    Bhansali, Rahul S.
    Lee, Sung June
    Kumar, Anil
    Lehman, Anne
    Loftus, Joseph Patrick
    Jeschke, Grace
    Crispino, John D.
    Besson, Thierry
    Shi, Junwei
    Swaminathan, Srividya
    BLOOD, 2020, 136
  • [45] Clonal Evolution Pattern and Prognostic Significance of Clonal Architecture in KMT2A-Rearranged Acute Myeloid Leukemia
    Matsuo, Hidemasa
    Yoshida, Kenichi
    Nannya, Yasuhito
    Ito, Yuri
    Saito, Shoji
    Koga, Yuhki
    Moritake, Hiroshi
    Terui, Kiminori
    Kawaguchi, Koji
    Okamoto, Yasuhiro
    Nakayama, Hideki
    Miyako, Kanno
    Hino, Moeko
    Akane, Yusuke
    Inoue, Akiko
    Shimada, Akira
    Goto, Hiroaki
    Ueno, Hiroo
    Takita, Junko
    Yamato, Genki
    Shiba, Norio
    Hayashi, Yasuhide
    Shiraishi, Yuichi
    Miyano, Satoru
    Kiyokawa, Nobutaka
    Tomizawa, Daisuke
    Taga, Takashi
    Tawa, Akio
    Ogawa, Seishi
    Adachi, Souichi
    BLOOD, 2021, 138
  • [46] Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)
    Issa, Ghayas C.
    Aldoss, Ibrahim
    Thirman, Michael J.
    Dipersio, John
    Arellano, Martha
    Blachly, James S.
    Mannis, Gabriel N.
    Perl, Alexander
    Dickens, David S.
    Mcmahon, Christine M.
    Traer, Elie
    Zwaan, C. Michel
    Grove, Carolyn S.
    Stone, Richard
    Shami, Paul J.
    Mantzaris, Ioannis
    Greenwood, Matthew
    Shukla, Neerav
    Cuglievan, Branko
    Kovacsovics, Tibor
    Gu, Yu
    Bagley, Rebecca G.
    Madigan, Kate
    Chudnovsky, Yakov
    Nguyen, Huy Van
    Mcneer, Nicole
    Stein, Eytan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (01)
  • [47] KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia Cells Undergo ER-Stress-Induced Apoptosis Following Exposure to Proteasome Inhibitors
    Kim, Wonil
    Koss, Cary S.
    Gruber, Tanja A.
    BLOOD, 2019, 134
  • [48] Duplex Sequencing Uncovers Recurrent Low-frequency Cancer-associated Mutations in Infant and Childhood KMT2A-rearranged Acute Leukemia
    Pilheden, Mattias
    Ahlgren, Louise
    Hyrenius-Wittsten, Axel
    Gonzalez-Pena, Veronica
    Sturesson, Helena
    Marquart, Hanne Vibeke Hansen
    Lausen, Birgitte
    Castor, Anders
    Pronk, Cornelis Jan
    Barbany, Gisela
    Tamm, Katja Pokrovskaja
    Fogelstrand, Linda
    Lohi, Olli
    Noren-Nystrom, Ulrika
    Asklin, Johanna
    Chen, Yilun
    Song, Guangchun
    Walsh, Michael
    Ma, Jing
    Zhang, Jinghui
    Saal, Lao H.
    Gawad, Charles
    Hagstrom-Andersson, Anna K.
    HEMASPHERE, 2022, 6 (10): : E785
  • [49] Single-cell transcriptomics reveals a distinct developmental state of KMT2A-rearranged infant B-cell acute lymphoblastic leukemia
    Khabirova, Eleonora
    Jardine, Laura
    Coorens, Tim H. H.
    Webb, Simone
    Treger, Taryn D.
    Engelbert, Justin
    Porter, Tarryn
    Prigmore, Elena
    Collord, Grace
    Piapi, Alice
    Teichmann, Sarah A.
    Inglott, Sarah
    Williams, Owen
    Heidenreich, Olaf
    Young, Matthew D.
    Straathof, Karin
    Bomken, Simon
    Bartram, Jack
    Haniffa, Muzlifah
    Behjati, Sam
    NATURE MEDICINE, 2022, 28 (04) : 743 - +
  • [50] Immune Escape of KMT2A-rearranged B-ALL Via Myeloid Lineage Switch After CD19 CAR-T Therapy
    Van Arnam, John
    Luning-Prak, Eline
    Paessler, Michele
    Pillai, Vinodh
    MODERN PATHOLOGY, 2019, 32